Fecal microbiota transfer for refractory intestinal graft‐versus‐host disease — Experience from two German tertiary centers-Reference-Cited by-同舟云学术

Fecal microbiota transfer for refractory intestinal graft‐versus‐host disease — Experience from two German tertiary centers

Published:2021-06-09 Issue:2 Volume:107 Page:229-245
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Goeser Felix¹²³^ORCID,Sifft Barbara⁴,Stein‐Thoeringer Christoph⁵,Farowski Fedja²³⁶⁷,Strassburg Christian P.¹,Brossart Peter⁴,Higgins Paul G.²⁸,Scheid Christoph⁶,Wolf Dominik⁴⁹,Holderried Tobias A. W.⁴,Vehreschild Maria J. G. T.²³⁶⁷,Cruz Aguilar Marta Rebeca²³⁶

Affiliation:

1. Department of Internal Medicine I University Hospital Bonn Bonn Germany

2. German Center for Infection Research (DZIF), Partner Site Bonn‐Cologne Germany

3. German Clinical Microbiome Study Group (GCMSG) Germany

4. Department of Internal Medicine III Oncology, Hematology, Rheumatology and Immune‐Oncology University Hospital Bonn Bonn Germany

5. German Cancer Research Center (DKFZ) Heidelberg Germany

6. Department I of Internal Medicine Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf University of Cologne Cologne Germany

7. Department of Internal Medicine Infectious Diseases Goethe University Frankfurt Frankfurt am Main Germany

8. Institute for Medical Microbiology, Immunology and Hygiene University of Cologne Cologne Germany

9. UKIM 5 Hematology and Oncology Medical University Innsbruck Innsbruck Austria

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13642

Reference86 articles.

1. Graft-versus-host disease

2. Graft-versus-host disease

3. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

4. What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score

5. First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacomicrobiomics in precision cancer therapy: bench to bedside;Frontiers in Immunology;2024-09-09

2. Recent advances in acute gastrointestinal graft versus host disease (aGvHD): aspects of steroid-resistant disease;Annals of Hematology;2024-08-29

3. An enterococcal phage-derived enzyme suppresses graft-versus-host disease;Nature;2024-07-10

4. Fäkaler Mikrobiomtransfer bei GvHD und Komplikationen nach allogener Stammzelltransplantation: Ein vielversprechender Ansatz;Trillium Diagnostik;2024-06-20

5. Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract;Blood Advances;2024-04-26